EHC · XBRL financial data

Encompass Health financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (EHC's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Revenue from contracts with customers	1,247*	1,316	1,301	1,351	1,405*	1,455	1,458	1,478	1,545*	1,587	1,597	1,610
General and administrative	53*	50	51	54	55*	52	59	56	68*	58	63	60
Interest expense	35*	35	34	35	33*	32	30	31	30*	32	33	32
Other income (expense)	9*	5	3	9	2*	3	7	6	4*	19	9	2
Income tax expense (benefit)	37*	38	38	36	38*	42	51	45	55*	56	54	53
Net income (loss)	88*	113	114	108	121*	152	142	127	146*	195	154	150
Earnings per share, basic USD per share	0.88*	1.12	1.13	1.08	1.21*	1.50	1.41	1.26	1.46*	1.96	1.55	1.52
Earnings per share, diluted USD per share	0.86*	1.10	1.12	1.06	1.18*	1.48	1.39	1.24	1.43*	1.93	1.54	1.50
Weighted average shares, basic millions of shares	100*	100	100	100	100*	101	101	101	100*	99	99	98
Weighted average shares, diluted millions of shares	102*	102	102	102	102*	102	102	102	102*	101	100	100

Fiscal quarters (EHC's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Cash and cash equivalents	69	134	154	148	85	96	99	49	72	111	108	76
Accounts receivable	600	—	—	—	593	—	—	—	613	—	—	—
Total current assets	842	930	938	934	887	911	918	870	906	1,029	1,041	1,013
Right-of-use asset	209	199	216	210	204	219	216	218	213	205	198	195
Goodwill	1,281	1,281	1,284	1,284	1,284	1,284	1,303	1,303	1,318	1,318	1,324	1,324
Total assets	6,102	6,231	6,389	6,458	6,535	6,641	6,786	6,866	7,090	7,313	7,458	7,567
Accounts payable	170	166	164	170	171	159	175	138	178	204	222	231
Accrued liabilities	—	—	—	—	31	—	—	—	55	—	—	—
Total current liabilities	656	680	695	897	841	856	865	762	836	877	873	927
Lease liability, non-current	196	186	202	196	190	204	201	203	197	189	181	176
Total liabilities	3,805	3,828	3,859	3,733	3,686	3,704	3,698	3,679	3,814	3,946	3,996	4,005
Retained earnings	407	—	—	—	797	—	—	—	1,289	—	—	—
Total stockholders' equity	1,648	1,742	1,839	1,960	2,067	2,159	2,280	2,374	2,438	2,522	2,598	2,681
Total liabilities and equity	6,102	6,231	6,389	6,458	6,535	6,641	6,786	6,866	7,090	7,313	7,458	7,567
Common shares outstanding (cover page) millions of shares	100	101	101	101	101	101	101	101	99	99	99	98

Fiscal quarters (EHC's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Net income (loss)	88*	113	114	108	121*	152	142	127	146*	195	154	150
Stock-based compensation	13*	9	14*	13*	13*	10	14*	14*	18*	12	14*	15*
Depreciation and amortization	70*	70	73	78	78*	79	80	82	86*	87	90	96
Net cash from investing activities	(208)*	(130)	(158)*	(162)*	(204)*	(159)	(165)*	(201)*	(239)*	(150)	(236)*	(242)*
Share repurchases	0*	0	17*	7*	8*	32	25*	25*	76*	72	74*	58*
Dividends paid	15*	16	15*	15*	17*	18	17*	17*	19*	20	19*	19*
Net cash from financing activities	(30)*	(41)	(50)*	(90)*	(151)*	(130)	(90)*	(113)*	(97)*	(103)	(77)*	(154)*
Net change in cash	(37)*	69	9*	17*	(76)*	(0)	15*	(44)*	9*	61	(30)*	(33)*

SIC 8060 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8060 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
Encompass Health	76	1,610	362*	98.1M	Q3 FY26 10-QSep 30, 2026
Tenet Healthcare	2,674	5,631	1,281*	79.6M	Q3 FY26 10-QSep 30, 2026
Universal Health Services	139	4,638	443*	not reported	Q2 FY26 10-QJun 30, 2026
Surgery Partners	217	not reported	59*	130.9M	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.